Logo
Facebook
Linkedin
X
Youtube
Linkedin
Twitter
Youtube
Facebook
Sat 8 August 2026
Logo
  • Drug Discovery and Development
    • Drug Discovery
    • IND
    • Phase 1-2 trials
    • Phase 3 trials
    • Approvals
  • Finance
  • Conferences
  • Journal
    • Drug DiscoveryINDPhase 1-2 trialsPhase 3 trialsApprovals

      Orexo announces positive outcome from in vivo study of OX390

      19 June 2026

      MEKanistic Therapeutics announces FDA clearance of IND for MTX-531, enabling phase 1 trials in advanced solid tumours

      19 June 2026

      Matter Bio files first IND for Lm-LLO-TT, advancing first-in-human phase 1/2a study in patients with pancreatic cancer

      19 June 2026

      Myosin Therapeutics initiates phase 1/2 trial of MT-125 targeting non-muscle myosin II in newly diagnosed glioblastoma

      19 June 2026

      New clinical study shows pasteurised Akkermansia muciniphila MucT supports weight loss maintenance

      19 June 2026
  • Products
  • CDMO
  • CRO

EDITOR PICKS

Orexo announces positive outcome from in vivo study of OX390

19 June 2026

MEKanistic Therapeutics announces FDA clearance of IND for MTX-531, enabling phase...

19 June 2026

Matter Bio files first IND for Lm-LLO-TT, advancing first-in-human phase 1/2a...

19 June 2026

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • June 2025

Categories

  • Approvals
  • CDMO
  • Conferences and events
  • Conferences archive
  • CRO
  • Drug Discovery
  • Finance, mergers and appointments
  • IND
  • Journal
  • Pharma Packaging and Logistics
  • Phase 1-2 trials
  • Phase 3 trials
  • Products and services

POPULAR POSTS

Centauri Therapeutics publishes proof-of-concept data demonstrating activity of a novel bifunctional...

18 July 2025

Ilmac Basel: everything you need to know

1 July 2025

Lilly presents first clinical data for next-generation FRα targeting ADC in...

13 June 2025

POPULAR CATEGORY

  • Finance, mergers and appointments21
  • Phase 1-2 trials18
  • Drug Discovery17
  • Phase 3 trials17
  • Approvals13
  • IND7
  • Conferences and events7
  • CDMO3
  • Products and services3
ABOUT US
FOLLOW US
Facebook Linkedin X Website Youtube
  • About us
  • Advertise / Partner
  • Contact
  • Editorial standards
  • Terms and conditions
©